0000858452-11-000020.txt : 20110804 0000858452-11-000020.hdr.sgml : 20110804 20110804101936 ACCESSION NUMBER: 0000858452-11-000020 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110804 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110804 DATE AS OF CHANGE: 20110804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSCEND SERVICES INC CENTRAL INDEX KEY: 0000858452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 330378756 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18217 FILM NUMBER: 111009087 BUSINESS ADDRESS: STREET 1: ONE GLENLAKE PARKWAY STREET 2: SUITE 1325 CITY: ATLANTA STATE: GA ZIP: 30328 BUSINESS PHONE: 678-808-0613 MAIL ADDRESS: STREET 1: ONE GLENLAKE PARKWAY STREET 2: SUITE 1325 CITY: ATLANTA STATE: GA ZIP: 30328 FORMER COMPANY: FORMER CONFORMED NAME: TRICARE INC DATE OF NAME CHANGE: 19920703 8-K 1 trcr8-k20112qearningsrelea.htm FORM 8-K TRCR 8-K 2011 2Q Earnings Release


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
___________________

FORM 8-K
___________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 4, 2011
___________________

TRANSCEND SERVICES, INC.
(Exact name of registrant as specified in its charter)
___________________


Delaware
0-18217
33-0378756
(State or other jurisdiction of incorporation)
(Commission file number)
(I.R.S. Employer Identification No.)


One Glenlake Parkway, Suite 1325, Atlanta, GA 30328
(Address of principal executive offices, including zip code)

(678) 808-0600
(Registrant's telephone number, including area code)
___________________



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 















Item 2.02. Results of Operations and Financial Condition.
    
(a) On August 4, 2011, Transcend Services, Inc. issued a press release announcing its operating results and certain other related information for the three months and six months ended June 30, 2011. A copy of the press release is attached hereto as Exhibit 99.1.

The information contained in this Item 2.02 and the exhibit hereto are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information contained in this Item 2.02 and the exhibit hereto shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit is furnished as part of this Current Report pursuant to Item 2.02.

Exhibit 99.1    Press release of Transcend Services, Inc. dated August 4, 2011.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                        

 
 
Transcend Services, Inc.
 
 
 
 
 
Date: August 4, 2011
 
/s/ Lance Cornell
 
 
 
Lance Cornell
 
 
Chief Financial Officer
 
 
(Principal Financial Officer)




EX-99.1 2 trcr8-k20112qerex991.htm EX-99.1 TRCR 8-K 2011 2Q ER Ex 99.1


Exhibit 99.1
FOR IMMEDIATE RELEASE

Contacts:
Neil Berkman, Investor Relations, 310-477-3118, nberkman@berkmanassociates.com
Larry Gerdes, Chief Executive Officer, 678-808-0600, larry.gerdes@trcr.com
Lance Cornell, Chief Financial Officer, 678-808-0600, lance.cornell@trcr.com


August 4, 2011
(BW) (TRANSCEND SERVICES, INC.) (TRCR)

TRANSCEND REPORTS EARNINGS PER SHARE OF $0.33 AND 38% REVENUE GROWTH FOR THE SECOND QUARTER OF 2011

Atlanta, Georgia. TRANSCEND SERVICES, INC. (NASDAQ: TRCR), a leading provider of clinical documentation solutions to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2011.

Second Quarter Results

Transcend's diluted earnings per share increased to $0.33 for the second quarter of 2011 compared to $.15 for the second quarter of 2010. During the second quarter of 2011, the Company incurred $139,000 of acquisition-related transaction costs which impacted diluted earnings per share by approximately $(.01). The results for 2010 include the $(.06) per diluted share impact of two unusual expenses: $601,000 of transaction fees related to an unsuccessful acquisition and $445,000 related to a cumulative stock-based compensation adjustment. Excluding these two unusual expenses, non-GAAP diluted earnings per share for the second quarter of 2010 was $.21 (see table below for a reconciliation of GAAP to non-GAAP results). The improvement in earnings was primarily due to the positive impact of acquisitions and gross margin improvement.
  
Revenue for the second quarter of 2011 increased $8,453,000 or 38% to $30,662,000 compared to $22,209,000 for the second quarter of 2010, including $6,729,000 of revenue contributed by the Heartland and DTS acquisitions. Excluding these two recent acquisitions, revenue increased 8%.

Gross profit for the second quarter of 2011 increased 53% to $12,313,000, or 40% of revenue, compared to $8,031,000, or 36% of revenue, for the second quarter of 2010.

Operating income for the second quarter of 2011 increased 120% to $5,934,000, or 19% of revenue, compared to $2,692,000, or 12% of revenue, for the second quarter of 2010. Excluding the two unusual 2010 expenses mentioned above, operating income increased 59% for the second quarter of 2011 compared to non-GAAP operating income of $3,738,000 or 17% of revenue for the same quarter of last year.

The effective income tax rate for the second quarter of 2011 was 40% compared to 41% in the second quarter of 2010.

Net income for the second quarter of 2011 increased 131% to $3,624,000 compared to $1,568,000 for the second quarter of 2010. Excluding the two unusual expenses mentioned above, net income for the second quarter of 2011 increased 59% compared to non-GAAP net income of $2,273,000 for the second quarter of 2010.






As of June 30, 2011, the Company had $22,393,000 of cash, cash equivalents and short-term investments on hand, $30,349,000 of net working capital and no debt outstanding. During the second quarter of 2011, the Company acquired DTS America, Inc. (“DTS”) for a net cash investment of $8,781,000 (plus $600,000 to be paid in the future). The Company also invested $1,446,000 in capital expenditures and capitalized software development costs during the second quarter, including $1,017,000 related to Transcend's new Encore transcription platform.

Table to Reconcile GAAP Results to Non-GAAP Results for the Quarter ended June 30, 2010
In Thousands, Except Per Share Amounts
(Note: Only GAAP numbers are reported for the second quarter of 2011)

 
Non-GAAP Results
Acquisition-Related Costs
Stock
Compensation Adjustment
GAAP Results
 
 
 
 
 
Operating Income
$
3,738

$
(601
)
$
(445
)
$
2,692

 
 
 
 
 
Income Before Income Taxes
3,715

(601
)
(445
)
2,669

 
 
 
 
 
Income Taxes
1,442

(233
)
(108
)
1,101

 
 
 
 
 
Net Income
$
2,273

$
(368
)
$
(337
)
$
1,568

 
 
 
 
 
Weighted Avg. Shares Outstanding - Diluted
10,793

10,793

10,793

10,793

 
 
 
 
 
Diluted Earnings Per Share
$
0.21

$
(0.03
)
$
(0.03
)
$
0.15


Year-to-Date Results

Revenue increased $15,545,000, or 35%, to $59,960,000 for the six months ended June 30, 2011 compared to revenue of $44,415,000 in the same period in 2010. Gross profit increased $8,966,000, or 58%, to $24,477,000 in the six months ended June 30, 2011 compared to $15,511,000 in the same period in 2010. Gross profit as a percentage of revenue increased to 41% in the six months ended June 30, 2011 compared to 35% for the same period in 2010. Operating income increased $7,083,000, or 138%, to $12,219,000 in the six months ended June 30, 2011, compared to $5,136,000 in the same period in 2010. Included in 2011 and 2010 operating expenses are acquisition-related costs of $221,000 and $1,279,000, respectively. The costs for 2010 were related to an unsuccessful acquisition. Also included in 2010 is a $676,000 cumulative adjustment for stock-based compensation expense. The effective tax rate was 40% for both periods. Net income increased $4,338,000, or 142%, to $7,385,000 in the six months ended June 30, 2011, compared to $3,047,000 in the same period in 2010. Fully diluted earnings per share increased $0.39, to $0.67 for the six months ended June 30, 2011, compared to $0.28 for the same period in 2010.

Operations Review and Outlook

Susan McGrogan, President and Chief Operating Officer, stated: “I am extremely pleased to report that during the second quarter, we sold new business that we expect to generate between $6.4 million and $7.9 million of annual revenue once fully implemented. This was the strongest sales quarter we have had in recent years and should positively impact our organic revenue growth rates in the fourth quarter. We typically see lighter volumes in the second and third quarters and this year was no exception. The sequential quarter impact of seasonality is roughly 1% of revenue and $(.01) per diluted share.”

“Our gross profit margin increased four points compared to the same quarter last year, from 36% to 40%,” continued Ms. McGrogan. “This was down a little over one point from the first quarter of 2011. About half of the sequential quarter decline is attributable to the impact of the DTS acquisition and the remainder is





primarily a result of investments in personnel to manage our growth. We expect to be able to improve the DTS margins over the next 18 months as we integrate the operations and convert some of the DTS customers to our platform. We edited 85% of our BeyondTXT and 77% of our Gemstar platform volume using speech recognition technology in the second quarter, which was about the same as the first quarter and compares to 72% of our BeyondTXT volume in the second quarter of 2010. We processed 37% of our work offshore in the second quarter, about the same as the first quarter and up from 17% in the second quarter of last year due to the Heartland acquisition.

Lance Cornell, Chief Financial Officer, added: “We continue to make progress on our integration of Heartland, particularly in India, and we are in the middle of the first stage of the DTS integration. Both are progressing according to our plans and DTS was slightly accretive to earnings in the second quarter excluding transaction costs. We were excited to announce the acquisition of Baltimore-based Salar earlier this week. Our strategy is to offer complete clinical documentation solutions for our customers, giving them as much flexibility as possible to choose different methods for documenting patient care depending on the unique needs of the physicians and the hospital. If they choose dictation, we offer our traditional outsourced transcription services or a platform for their in-house transcription department. If they choose physician self-editing solutions, we can offer our BeyondSpeech solution for Radiology and expect to be able to offer a solution for HIM as a module of Encore around the end of the year. And some customers will prefer template-based solutions for certain types of documentation. Salar's TeamNotesTM product meets that need with a highly customized approach that maximizes physician productivity and adoption, particularly in cases where electronic medical record implementations have not realized their potential. We are excited to work with Todd Johnson and his team at Salar to integrate the Salar products into our clinical documentation strategy.”

Larry Gerdes, Chief Executive Officer, concluded: “A significant milestone in our history occurred on June 27th, when we announced the general availability of EncoreTM, our new SaaS transcription platform. We have invested significant resources into the development of EncoreTM and we are excited about the role this new platform will play in our future. We plan to migrate all of the customers on our BeyondTXT and Gemstar platforms to EncoreTM over the next two years. I want to congratulate our technical teams for this success. As we look forward, we plan to build on our second quarter sales momentum and our new offerings - both acquired and internally developed - to provide the industry with a robust suite of products and services to meet their clinical documentation needs. This is a very busy and exciting time for our employees and I want to thank everyone at Transcend for their diligence and loyalty to our customers.

Conference Call

Transcend will host a conference call regarding this press release for investors, analysts and other interested parties on August 4, 2011 at 11:00 a.m. Eastern time. To participate in the conference call, please dial (800) 815-8193 (the US/Canada dial-in number) or (706) 643-2724 (the international dial-in number), enter the conference identification number 82233515 and, if asked, identify the conference name as Transcend Services and the leader name as Larry Gerdes. A replay of the conference call will be available by dialing (800) 642-1687 (US/Canada) or (706) 645-9291 (international) and entering the conference identification number 82233515 from two hours after the completion time of the conference call until midnight on August 11, 2011.



About Transcend Services, Inc.

Transcend Services is a leading provider of clinical documentation solutions for healthcare organizations. Our high-quality transcription services - along with our physician self-edit and template solutions, data extraction and reporting tools - provide critical data needed to document patient encounters and help drive





clinical decision making. We provide our clients with exceptional quality, turnaround time and service so that they can focus on what matters most - their patients.  For more information, visit www.transcendservices.com.

Statement Regarding Use of Non-GAAP Financial Measures

The Company has used non-GAAP financial measures of operating income, income before income taxes, net income and earnings per diluted share for 2010 in this earnings release and anticipates using some or all of these measures in the earnings conference call on August 4, 2011. These measures should not be considered in isolation or as a substitute for GAAP operating income, income before income taxes, net income, earnings per diluted share or other performance measures prepared in accordance with GAAP. The Company used these non-GAAP measures of operating performance because it allowed us to more easily compare past performance consistently over various periods and improves our ability to assess future performance. A non-GAAP financial measure is a numerical measure of financial performance, financial position, or cash flows that either 1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with GAAP in the statement of operations, balance sheet or statement of cash flows, or 2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented.

Safe Harbor Statement

This press release contains certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that represent our expectations, anticipations or beliefs about future events, including our operating results, financial condition, liquidity, expenditures, and compliance with legal and regulatory requirements. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially depending on a variety of important factors. Factors that might cause or contribute to such differences include, but are not limited to, competitive pressures, extraordinary expenses, loss of significant customers, the mix of revenue, changes in pricing policies, delays in revenue recognition, challenges encountered in integrating acquired businesses, increased regulatory burdens, lower-than-expected demand for the Company's products and services, failure to expand customer relationships or realize revenues from sales closed in the current quarter, the Company's position for growth, delays in the development of the Company's transcription platform, business conditions in the integrated health care delivery network market, adverse general economic conditions, resolution of uncertain tax positions, foreign currency exchange rates and the risk factors detailed in our periodic, quarterly and annual reports on Forms 8-K, 10-Q and 10-K that we file with the Securities Exchange Commission ("SEC") from time to time. With respect to such forward-looking statements, we claim protection under the Private Securities Litigation Reform Act of 1995. Our SEC filings are available from us, and also may be examined at public reference facilities maintained by the SEC or, to the extent filed via EDGAR, accessed through the website of the SEC (http://www.sec.gov). In addition, factors that we are not currently aware of could harm our future operating results. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to make any revisions to the forward-looking statements or to reflect events or circumstances after the date of this press release.

(Unaudited Financial Statements Follow)






TRANSCEND SERVICES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited and rounded to the nearest thousand,
except earnings per share)
 
 
Three months ended
June 30,
 
Six months ended
June 30,
 
2011
  
2010
 
2011
 
2010
Revenue
$
30,662,000

  
$
22,209,000

 
$
59,960,000

 
$
44,415,000

     Direct costs
18,349,000

  
14,178,000

 
35,483,000

 
28,904,000

Gross profit
12,313,000

  
8,031,000

 
24,477,000

 
15,511,000

     Operating expenses:
 
  
 
 
 
 
 
     Sales and marketing
638,000

  
535,000

 
1,052,000

 
938,000

     Research and development
1,010,000

  
408,000

 
1,906,000

 
834,000

     General and administrative
3,534,000

  
2,695,000

 
7,075,000

 
5,585,000

     Stock-based compensation
306,000

 
640,000

 
576,000

 
831,000

     Acquisition-related costs
139,000

 
601,000

 
221,000

 
1,279,000

     Depreciation and amortization
752,000

  
460,000

 
1,428,000

 
908,000

     Total operating expenses
6,379,000

  
5,339,000

 
12,258,000

 
10,375,000

Operating income
5,934,000

  
2,692,000

 
12,219,000

 
5,136,000

Interest and other expenses, net
(74,000
)
 
23,000

 
(52,000
)
 
50,000

Income before income taxes
6,008,000

  
2,669,000

 
12,271,000

 
5,086,000

     Income tax provision
2,384,000

  
1,101,000

 
4,886,000

 
2,039,000

Net income
$
3,624,000

  
$
1,568,000

 
$
7,385,000

 
$
3,047,000

 
 

  
 

 
 
 
 
Basic earnings per share:
 
  
 
 
 
 
 
     Net earnings per share
$
0.34

  
$
0.15

 
$
0.70

 
$
0.29

     Weighted average shares outstanding
10,651,000

  
10,489,000

 
10,625,000

 
10,486,000

 
 

  
 

 
 
 
 
Diluted earnings per share:
 
  
 
 
 
 
 
     Net earnings per share
$
0.33

  
$
0.15

 
$
0.67

 
$
0.28

     Weighted average shares outstanding
11,063,000

  
10,793,000

 
11,025,000

 
10,839,000

 
 
  
 
 
 
 
 







TRANSCEND SERVICES, INC.
CONSOLIDATED BALANCE SHEETS
(Rounded to the nearest thousand)
 
 
June 30,
2011
(unaudited)
 
December 31,
2010
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
4,114,000

 
$
6,207,000

Short-term investments
18,279,000

 
20,454,000

Accounts receivable, net of allowance for doubtful accounts of $145,000 at June 30, 2011 and $124,000 at December 31, 2010
14,259,000

 
12,037,000

Deferred income tax, net
1,743,000

 
482,000

Prepaid expenses and other current assets
1,320,000

 
688,000

Total current assets
39,715,000

 
39,868,000

Property and equipment, net
3,136,000

 
2,976,000

Capitalized software development costs, net
5,087,000

 
3,188,000

Intangible assets, net
40,981,000

 
35,301,000

Deferred income tax, net
2,190,000

 
470,000

Other assets
371,000

 
414,000

Total assets
$
91,480,000

 
$
82,217,000

 
 

 
 

LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
2,008,000

 
$
1,653,000

Accrued compensation expense
3,955,000

 
3,666,000

Promissory notes payable

 
67,000

Income tax payable
847,000

 
1,193,000

Other accrued liabilities
2,556,000

 
2,180,000

Total current liabilities
9,366,000

 
8,759,000

Long term liabilities:
 
 
 
Income tax contingencies
2,682,000

 
2,606,000

Other liabilities
585,000

 
689,000

Total long term liabilities
3,267,000

 
3,295,000

Commitments and contingencies
 
 
 
Stockholders' equity:
 
 
 
Preferred stock, $0.01 par value; 2,000,000 shares authorized and no shares outstanding at June 30, 2011 and December 31, 2010
-
 
-
Common stock, $0.05 par value; 30,000,000 shares authorized at June 30, 2011 and December 31, 2010; 10,671,000 and 10,566,000 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively
533,000

 
528,000

Additional paid-in capital
64,662,000

 
63,368,000

Retained earnings
13,652,000

 
6,267,000

Total stockholders' equity
78,847,000

 
70,163,000

Total liabilities and stockholders' equity
$
91,480,000

 
$
82,217,000